Synthetic Lethality as a Targeted Approach to Advanced Prostate Cancer

doi 10.21236/ada590822
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Polo-Like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction

Clinical Cancer Research
Cancer ResearchOncology
2019English

Synthetic Lethality in DNA Repair Network: A Novel Avenue in Targeted Cancer Therapy and Combination Therapeutics

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Advanced Prostate Cancer Presenting as Hemolytic Uremic Syndrome

Case Reports in Urology
2013English

Inhibition of dUTPase Induces Synthetic Lethality With Thymidylate Synthase-Targeted Therapies in Non-Small Cell Lung Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Immunotherapy Exposes Cancer Stem Cell Resistance and a New Synthetic Lethality

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Back to the Future: Mechanism-Based, Mutation-Specific Combination Chemoprevention With a Synthetic Lethality Approach

Cancer Prevention Research
MedicineCancer ResearchOncology
2011English

E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer

Cancer Discovery
Oncology
2018English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

Cancer-Specific Synthetic Lethality Between ATR and CHK1 Kinase Activities

Cell Reports
BiochemistryGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy